Stay updated on Pembrolizumab in Hypermutation Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-18T20:27:33.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.3 released. The page content appears unchanged aside from the version label.
    Difference
    0.0%
    Check dated 2026-03-11T17:36:12.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Results have been posted for the study, including ORR, PFS, and OS outcomes with posting dates. The page now includes links to the study protocol and statistical analysis plan.
    Difference
    3%
    Check dated 2026-03-04T13:39:04.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The government funding lapse notice and the v3.4.1 revision information were removed.
    Difference
    0.4%
    Check dated 2026-02-11T06:18:00.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the site version to v3.4.1, replacing v3.4.0; these are administrative UI changes that do not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T04:43:08.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' and 'Last Update Submitted that Met QC Criteria', along with a new site revision (v3.4.0). The previous indicators like 'No Results Posted' and related status text have been removed.
    Difference
    0.3%
    Check dated 2026-01-28T02:59:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.